4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-25-006718
EVP R&D, Chief Medical Officer gave up 8,866 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 19,968 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-22 | Exercise or conversion : show line 1 in the form | +12,279 | 75,100 | D | ||
| 2025-02-22 | Shares withheld for taxes : show line 2 in the form | −5,452 | $35.32 | $192,565 | 69,648 | D |
| 2025-02-23 | Exercise or conversion : show line 3 in the form | +7,689 | 77,337 | D | ||
| 2025-02-23 | Shares withheld for taxes : show line 4 in the form | −3,414 | $35.32 | $120,582 | 73,923 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-22 | Exercise or conversion : show line 5 in the form Restricted Stock Unit Award | −12,279 | 0 | D |
| 2025-02-23 | Exercise or conversion : show line 6 in the form Restricted Stock Unit Award | −7,689 | 15,379 | D |
Loading xslF345X05/form4.xml…